Status: current, Primitive. Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3784477018 | Selinexor | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3784478011 | Selinexor (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Selinexor | Is a | Triazole | false | Inferred relationship | Some | ||
| Selinexor | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Selinexor | Is a | Substance with triazole structure | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Selinexor-containing product | Has active ingredient | True | Selinexor | Inferred relationship | Some | 1 |
| Selinexor only product | Has active ingredient | True | Selinexor | Inferred relationship | Some | 1 |
| Selinexor-containing product in oral dose form | Has active ingredient | True | Selinexor | Inferred relationship | Some | 1 |
| Selinexor only product in oral dose form | Has active ingredient | True | Selinexor | Inferred relationship | Some | 1 |
| Selinexor 20 mg oral tablet | Has BoSS | True | Selinexor | Inferred relationship | Some | 1 |
| Selinexor 20 mg oral tablet | Has precise active ingredient | True | Selinexor | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR